NCT06278610

Brief Summary

Growing evidence in literature is supporting the role of ultrasound scan (US) as accurate tool in diagnosis and staging of gynecologic cancers. In particular, different studies demonstrated the accuracy of US in assessing endometrial, cervical, and ovarian cancer in the primary setting. However, the number of studies investigating the role of US in the recurrent setting is limited. Moreover, there is no evidence in literature exploring the role of US in laterally-extended pelvic recurrences from gynecologic cancer, where the Magnetic Resonance Imaging (MRI) scan is still considered the most accurate tool.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
85

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 19, 2020

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

February 27, 2023

Completed
12 months until next milestone

First Posted

Study publicly available on registry

February 26, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
Last Updated

May 21, 2024

Status Verified

May 1, 2024

Enrollment Period

4.1 years

First QC Date

February 27, 2023

Last Update Submit

May 20, 2024

Conditions

Keywords

pelvicresectionexenteration

Outcome Measures

Primary Outcomes (1)

  • pelvic exenteration resection.

    The accuracy of US in the assessment of pelvic structures involvement in recurrent/persistent gynecologic tumors with disease limited to the pelvis.

    30 minutes

Secondary Outcomes (1)

  • accuracy of US with the accuracy of MRI

    1 week

Interventions

PELVIC EXENTERATIONDIAGNOSTIC_TEST

PELVIC EXENTERATION

Also known as: Diagnostic Test: For example, imaging,, Procedure/Surgery

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing pelvic evisceration and lateral pelvic resection

You may qualify if:

  • All consecutive patients with histologically-proven recurrent or persistent gynecological cancer who are planned to undergo pelvic exenteration or laterally extended pelvic resection, both with curative and with palliative intent.
  • Anterior/total pelvic exenteration
  • Laterally extended endopelvic resection (LEER)
  • Laterally extended pelvic resection (LEPR) is defined as an en bloc lateral resection of a pelvic tumor involving sidewall muscle, and/or bone, and/or major nerve, and/or major vascular structure
  • With or without stoma formation

You may not qualify if:

  • Radical hysterectomy without lateral resection
  • Rectal resection only (posterior exenteration)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roma, 00168, Italy

RECRUITING

MeSH Terms

Interventions

Diagnostic Tests, RoutineDiagnostic Imaging

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Study Officials

  • ANTONIA CARLA TESTA, PROF

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2023

First Posted

February 26, 2024

Study Start

November 19, 2020

Primary Completion

December 30, 2024

Study Completion

January 31, 2025

Last Updated

May 21, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations